The American laboratory Johnson & Johnson announced, this Friday (12), plans to split into two entities, transforming its branch of hygiene products and over-the-counter medicines into a separate company.
This will entail creating “two world leaders who will be better positioned to deliver better healthcare outcomes for patients and consumers through innovation,” J&J said in a statement.
This is the third major company this week to announce a plan to split its business after General Electric and Toshiba.
J&J plans to complete its separation within 18 to 24 months, creating two different publicly traded companies.
According to its executive director, Alex Gorsky, he said the decision was taken after a “full assessment”.
The board and management see the division as “the best way to accelerate our efforts to serve patients, consumers and healthcare professionals, create opportunities for our talented global team, grow with benefits, and most importantly, improve care outcomes. for people around the world,” he said.
Gorsky added that the separation “highlights our focus on providing industry-leading innovations in the biopharmaceutical and medical device industry, with the goal of bringing new patient and healthcare system solutions to market while creating sustainable value for the shareholders”.
The company also said its 136,000 employees worldwide “will remain the backbone of this business.”
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.